Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
THZ1
Description:
A small-molecule inhibitor of cyclin-dependent kinase 7 studied in cancer biology and drug development.
Related topics:
Cancer-related Molecular Pathways (8%),
Genomics and Chromatin Dynamics (7%)
Wikidata ID:
wiki/Q27088991
OpenAlex ID:
keywords/thz1
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
2014
·
Nicholas Kwiatkowski
, Tinghu Zhang
, et al.
·
Nature
·
931
Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor
2014
·
Camilla L. Christensen
, Nicholas Kwiatkowski
, et al.
·
Cancer Cell
·
480
PDF
Correction: Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
2017
·
Florencia Cayrol
, Pannee Praditsuktavorn
, et al.
·
Nature Communications
·
222
PDF
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
2016
·
Yan-Yi Jiang
, De-Chen Lin
, et al.
·
Gut
·
218
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
2015
·
Kyle A. Nilson
, Jiannan Guo
, et al.
·
Molecular Cell
·
199
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma
2018
·
Amanda Balboni Iniguez
, Björn Stolte
, et al.
·
Cancer Cell
·
187
PDF
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
2016
·
A Harrod
, J Fulton
, et al.
·
Oncogene
·
187
PDF
Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle Phenotype
2019
·
Calla M. Olson
, Yanke Liang
, et al.
·
Cell chemical biology
·
184
PDF
Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma
2019
·
Felice Ho‐Ching Tsang
, Cheuk‐Ting Law
, et al.
·
Hepatology
·
169
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
2018
·
Mei Zeng
, Nicholas P Kwiatkowski
, et al.
·
eLife
·
162
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression
2018
·
Maria Rusan
, Kapsok Li
, et al.
·
Cancer Discovery
·
154
PDF
Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma
2018
·
Demeng Chen
, Zhiqiang Zhao
, et al.
·
Bone Research
·
153
PDF
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation
2019
·
Reyaz ur Rasool
, Ramakrishnan Natesan
, et al.
·
Cancer Discovery
·
133
Strategically targeting MYC in cancer
2016
·
Valeriya Posternak
, Michael D. Cole
·
F1000Research
·
119
PDF
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma
2017
·
Jiang Yuan
, Yan-Yi Jiang
, et al.
·
Cancer Research
·
112
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
2017
·
Florencia Cayrol
, Pannee Praditsuktavorn
, et al.
·
Nature Communications
·
107
PDF
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer
2017
·
Bo Li
, Triona Ni Chonghaile
, et al.
·
Cancer Research
·
104
A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification
2018
·
Christopher M. Browne
, Baishan Jiang
, et al.
·
Journal of the American Chemical Society
·
96
CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
2020
·
Jian Wang
, Ruiguang Zhang
, et al.
·
Journal of Hematology & Oncology
·
94
PDF
Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
2021
·
Lin Xia
, Zaozao Zheng
, et al.
·
Cancer Immunology Research
·
83
PDF
Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors
2017
·
Yang Gao
, Tinghu Zhang
, et al.
·
Cell chemical biology
·
81
PDF
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
2019
·
Bowen Sun
, Seth Mason
, et al.
·
Oncogene
·
80
PDF
Preclinical Efficacy and Molecular Mechanism of Targeting CDK7-Dependent Transcriptional Addiction in Ovarian Cancer
2017
·
Zhenfeng Zhang
, Huixin Peng
, et al.
·
Molecular Cancer Therapeutics
·
79
High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma
2018
·
Philip Eliades
, Brian J. Abraham
, et al.
·
Journal of Investigative Dermatology
·
76
PDF
THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer
2019
·
Ping Lu
, Jing Geng
, et al.
·
Oncogene
·
75
Show more works
View as search
Works count:
308
Citation count:
6,901
Year
Topic
Type